Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
29.69
+1.40 (4.95%)
Jul 27, 2026, 12:17 PM EDT - Market open
Faeth Therapeutics Market Cap
Faeth Therapeutics has a market cap or net worth of $765.37 million as of July 27, 2026. Its market cap has increased by 8,599.76% in one year.
Market Cap
765.37M
Enterprise Value
563.87M
1-Year Change
8,599.76%
Ranking
Category
Stock Price
$29.69
ChartMarket Cap Chart
Since February 4, 2021, Faeth Therapeutics's market cap has increased from $558.65M to $765.37M, an increase of 37.00%. That is a compound annual growth rate of 5.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 765.37M | 5,587.12% |
| Dec 31, 2025 | 13.46M | 9.18% |
| Dec 31, 2024 | 12.33M | -28.74% |
| Dec 29, 2023 | 17.30M | -62.21% |
| Dec 30, 2022 | 45.77M | -74.21% |
| Dec 31, 2021 | 177.46M | -68.23% |
| Feb 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tenax Therapeutics | 742.36M |
| Monopar Therapeutics | 735.99M |
| Design Therapeutics | 735.74M |
| Climb Bio | 735.23M |
| Aclaris Therapeutics | 730.44M |
| Omeros | 708.55M |
| BridgeBio Oncology Therapeutics | 706.54M |
| CytomX Therapeutics | 705.36M |